#Neiman Marcus weighs possible sale of Bergdorf Goodman

#Neiman Marcus weighs possible sale of Bergdorf Goodman

“#Neiman Marcus weighs possible sale of Bergdorf Goodman” Bergdorf Goodman is exploring a potential sale — and one possible outcome is that it moves to a surprising address nearby, The Post has learned. Neiman Marcus, which has owned the storied Fifth Avenue luxury mecca since 1972, has been interviewing bankers, including for a possible sale,…

Read More
#Yum! and 7-Eleven franchisee Ampex Brands buys Au Bon Pain

#Yum! and 7-Eleven franchisee Ampex Brands buys Au Bon Pain

“#Yum! and 7-Eleven franchisee Ampex Brands buys Au Bon Pain” Yum! Brands and 7-Eleven franchisee Ampex Brands has purchased bakery and cafe chain Au Bon Pain, helping to expand its international reach. Financial terms were not disclosed. The seller was Panera Bread, part of privately held JAB Holding Co., which owns a range of companies…

Read More
#Ad spending expected to hit new highs post-COVID

#Ad spending expected to hit new highs post-COVID

“#Ad spending expected to hit new highs post-COVID” The advertising market is poised for a major rebound as the pandemic wanes, according to a new report. US advertising sales are expected to hit a new all-time high of $259 billion this year — up 12.5 percent — while global advertising spending is seen hitting a…

Read More
#Bristol-Myers Squibb sued for .4B over delayed cancer drug

#Bristol-Myers Squibb sued for $6.4B over delayed cancer drug

“#Bristol-Myers Squibb sued for $6.4B over delayed cancer drug” Bristol-Myers Squibb was sued for $6.4 billion on Thursday for allegedly delaying its Breyanzi cancer drug to avoid payments to shareholders of the former Celgene, which the drugmaker bought in 2019. According to a complaint in Manhattan federal court, Bristol-Myers failed to use contractually required “diligent efforts”…

Read More